Kevin A. Grimes, MD, MPH, FIDSA

Assistant Professor of Clinical Medicine, Academic Institute
Houston Methodist
Weill Cornell Medical College

Education & Training

Internship, University of Texas Health Science Center at Houston
Residency, University of Texas Health Science Center at Houston
Clinical Fellowship, University of Texas Health Science Center at Houston
MD, University of Texas Health Science Center at Houston

Single-center Outcomes After Liver Transplantation With SARS-CoV-2–Positive Donors: An Argument for Increased Utilization
Connor, AA, Adelman, MW, Mobley, CM, Moaddab, M, Erhardt, AJ, Hsu, DE, Brombosz, EW, Sanghvi, M, Lee Cheah, Y, Simon, CJ, Hobeika, MJ, Saharia, AS, Victor, DW, Kodali, S, Basra, T, Graviss, EA, Nguyen, DT, Elsaiey, A, Moore, LW, Nigo, M, Drews, AL, Grimes, KA, Arias, CA, Li, XC, Gaber, AO & Ghobrial, RM 2024, , Transplantation Direct, vol. 10, no. 4, pp. E1590.

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials
CORIMUNO-19 Collaborative Group, DisCoVeRy Study Group, ACTT-2 Study Group & ACTT-3 Study Group 2024, , EClinicalMedicine, vol. 69, 102472.

Bloodstream infections after solid organ transplantation: clinical epidemiology and antimicrobial resistance (2016–21)
Adelman, MW, Connor, AA, Hsu, E, Saharia, A, Mobley, CM, Victor, DW, Hobeika, MJ, Lin, J, Grimes, KA, Ramos, E, Pedroza, C, Brombosz, EW, Ghobrial, RM & Arias, CA 2024, , JAC-Antimicrobial Resistance, vol. 6, no. 1, 158, pp. dlad158.

Allogeneic, off-the-shelf, SARS-CoV-2-specific T cells (ALVR109) for the treatment of COVID-19 in high-risk patients
Vasileiou, S, Hill, LQ, Kuvalekar, M, Workineh, AG, Watanabe, A, Velazquez, Y, Lulla, S, Mooney, K, Lapteva, N, Grilley, BJ, Heslop, HE, Rooney, CM, Brenner, MK, Eagar, TN, Carrum, G, Grimes, KA, Leen, AM & Lulla, P 2023, , Haematologica, vol. 108, no. 7, pp. 1840-1850.

Baricitinib Treatment of Coronavirus Disease 2019 Is Associated With a Reduction in Secondary Infections
Sweeney, DA, Tuyishimire, B, Ahuja, N, Beigel, JH, Beresnev, T, Cantos, VD, Castro, JG, Cohen, SH, Cross, K, Dodd, LE, Erdmann, N, Fung, M, Ghazaryan, V, George, SL, Grimes, KA, Hynes, NA, Julian, KG, Kandiah, S, Kim, HJ, Levine, CB, Lindholm, DA, Lye, DC, Maves, RC, Oh, MD, Paules, C, Rapaka, RR, Short, WR, Tomashek, KM, Wolfe, CR & Kalil, AC 2023, , Open Forum Infectious Diseases, vol. 10, no. 5, ofad205, pp. ofad205.

Bloodstream infections in prolonged use of axillary-placed, intra-aortic balloon-pump support: A single-center study
Dreucean, D, Donahue, KR, Morton, C, Succar, L, Krisl, J, Agrawal, T, Perez, K, Jaramillo, T, Kim, J, Fida, N, Guha, A, Kassi, M, Yousefzai, R, Hussain, I, Grimes, K & Bhimaraj, A 2023, , Infection Control and Hospital Epidemiology, vol. 45, no. 3, pp. 1-3.

Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial
ACTT-4 Study Group 2022, , The Lancet Respiratory Medicine, vol. 10, no. 9, pp. 888-899.

Extensively Drug-Resistant Myroides odoratus in Critically Ill Patients: A Case Series and Literature Review.
ONeal, M, Labay, CE, Harris, JE, Musick, WL, Cernoch, PL, Grimes, KA, Lin, J, Shah, S & Ramos-Salazar, E 2022, , Case reports in infectious diseases, vol. 2022, pp. 6422861.

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial
ACTT-3 study group members 2021, , The Lancet Respiratory Medicine, vol. 9, no. 12, pp. 1365-1376.

Successful Treatment of Invasive Mucormycosis in Orthotopic Liver Transplant Population
Eubank, TA, Mobley, CM, Moaddab, M, Hobeika, MJ, ONeal, M, Musick, WL, Knight, JM, Galati, JS, Kodali, S, Shetty, A, Victor, DW, Saharia, A, Ghobrial, RM & Grimes, KA 2021, , Case reports in transplantation, vol. 2021, pp. 8667589.

Early Experience with COVID-19 and Solid Organ Transplantation at a US High-volume Transplant Center
Yi, SG, Rogers, AW, Saharia, A, Aoun, M, Faour, R, Abdelrahim, M, Knight, RJ, Grimes, K, Bullock, S, Hobeika, M, McMillan, R, Mobley, C, Moaddab, M, Huang, HJ, Bhimaraj, A, Ghobrial, RM & Gaber, AO 2020, , Transplantation, vol. 104, no. 11, pp. 2208-2214.

Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipients
Balogh, J, Gordon Burroughs, S, Boktour, M, Patel, S, Saharia, A, Ochoa, RA, McFadden, R, Victor, DW, Ankoma-Sey, V, Galati, J, Monsour, HP, Fainstein, V, Li, XC, Grimes, KA, Gaber, AO, Aloia, T & Ghobrial, RM 2016, , Liver Transplantation, vol. 22, no. 2, pp. 163-170.

Cytomegalovirus reactivation following chemoradiation for invasive cervical carcinoma
Schlumbrecht, M, Grimes, K & Brown, J 2011, , Gynecologic Oncology Reports, vol. 1, no. 1, pp. 22-23.

PCR-based assay using occult blood detection cards for detection of diarrheagenic Escherichia coli in specimens from U.S. travelers to Mexico with acute diarrhea
Grimes, KA, Mohamed, JA, DuPont, HL, Padda, RS, Jiang, ZD, Flores, J, Belkind-Gerson, J, Martinez-Sandoval, FG & Okhuysen, PC 2008, , Journal of Clinical Microbiology, vol. 46, no. 7, pp. 2227-2230.

Infectivity of a Cryptosporidium parvum isolate of cervine origin for healthy adults and interferon-? knockout mice
Okhuysen, PC, Rich, SM, Chappell, CL, Grimes, KA, Widmer, G, Feng, X & Tzipori, S 2002, , Journal of Infectious Diseases, vol. 185, no. 9, pp. 1320-1325.